154 related articles for article (PubMed ID: 1700754)
21. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.
Bach MA; Wallach D; Flageul B; Cottenot F
Clin Exp Immunol; 1983 Apr; 52(1):107-14. PubMed ID: 6345031
[TBL] [Abstract][Full Text] [Related]
22. A peptidoglycan protein complex purified from M. leprae cell walls contains most or all immunodominant M. leprae T-cell antigens.
Mutis T; van Schooten WC; de Vries RR
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):788-93. PubMed ID: 2681461
[TBL] [Abstract][Full Text] [Related]
23. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
24. Cross-reactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein.
Mustafa AS; Lundin KE; Meloen RH; Oftung F
Clin Exp Immunol; 2000 Apr; 120(1):85-92. PubMed ID: 10759768
[TBL] [Abstract][Full Text] [Related]
25. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
26. HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens.
Thole JE; Janson AA; Cornelisse Y; Schreuder GM; Wieles B; Naafs B; de Vries RR; Ottenhoff TH
J Immunol; 1999 Jun; 162(11):6912-8. PubMed ID: 10352313
[TBL] [Abstract][Full Text] [Related]
27. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
[TBL] [Abstract][Full Text] [Related]
28. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
[TBL] [Abstract][Full Text] [Related]
29. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors.
Mohagheghpour N; Gelber RR; Engleman EG
J Immunol; 1987 Jan; 138(2):570-4. PubMed ID: 2947952
[TBL] [Abstract][Full Text] [Related]
30. Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells.
Ottenhoff TH; Klatser PR; Ivanyi J; Elferink DG; de Wit MY; de Vries RR
Nature; 1986 Jan 2-8; 319(6048):66-8. PubMed ID: 2417123
[TBL] [Abstract][Full Text] [Related]
31. CD4+ T-cell responses to recombinant hsp65 and hsp18 of M. leprae and their trypsin-digested fragments in leprosy: diversity in HLA-DR restriction.
Mitra DK; Mehra NK; Maiti TK; Banerjee A; Taneja V; Rajalingam R; Ahuja RK; Bhattacharya BC
Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):518-28. PubMed ID: 8642214
[TBL] [Abstract][Full Text] [Related]
32. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
Merkenschlager M; Altmann DM; Ikeda H
J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
[TBL] [Abstract][Full Text] [Related]
33. DR3-restricted T cells from different HLA-DR3-positive individuals recognize the same peptide (amino acids 2-12) of the mycobacterial 65-kDa heat-shock protein.
Van Schooten WC; Elferink DG; Van Embden J; Anderson DC; De Vries RR
Eur J Immunol; 1989 Nov; 19(11):2075-9. PubMed ID: 2480902
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
35. Analysis of circulating immune complexes from leprosy patients for Mycobacterium leprae antigens.
Sinha S; Chaturvedi V; Mishra B; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):396-403. PubMed ID: 1282143
[TBL] [Abstract][Full Text] [Related]
36. The immunobiology of leprosy.
Kaplan G; Cohn ZA
Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
[TBL] [Abstract][Full Text] [Related]
37. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
[TBL] [Abstract][Full Text] [Related]
38. Human anti-idiotypic T lymphocyte clones are activated by autologous anti-rabies virus antibodies presented in association with HLA-DQ molecules.
UytdeHaag F; Claassen I; Bunschoten H; Loggen H; Ottenhoff T; Teeuwsen V; Osterhaus A
J Mol Cell Immunol; 1987; 3(3):145-55. PubMed ID: 2908179
[TBL] [Abstract][Full Text] [Related]
39. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
40. Associations between HLA-DRB1 alleles and leprosy in an Indonesian population.
Soebono H; Giphart MJ; Schreuder GM; Klatser PR; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):190-6. PubMed ID: 9251590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
